< 1 minute read
Sep. 18, 2021

BI-3406: A Potent and Selective SOS1/KRAS Inhibitor

BI-3406

potent and selective SOS1/KRAS inhibitor related cmpd in Ph. I for KRAS+ cancers from biochemical HTS and SBDD Cancer Discovery, Aug. 19, 2020 Boehringer Ingelheim, Vienna, AT

twitterlinkedinprintemail